Second Malignancy | List of Frontiers open access articles

Review

Published on 07 Apr 2022

Hypofractionated Whole-Breast Irradiation Focus on Coronary Arteries and Cardiac Toxicity—A Narrative Review

in Radiation Oncology

Camil Ciprian Mireştean
Roxana Irina Iancu
Dragoş Petru Teodor Iancu

Frontiers in Oncology

doi 10.3389/fonc.2022.862819

6,097 views
10 citations

Original Research

Published on 12 Jun 2023

Constructing a cancer stem cell related prognostic model for predicting immune landscape and drug sensitivity in colorectal cancer

in Pharmacogenetics and Pharmacogenomics

Jianfang Chen
Shuang Wu
Yu Peng
Yang Zhao
Yan Dong
Fengwei Ran
Haofei Geng
Kang Zhang
Jianjun Li
Shuo Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1200017

5,076 views
16 citations

Original Research

Published on 17 Oct 2016

Shorter Maintenance Therapy in Childhood Acute Lymphoblastic Leukemia: The Experience of the Prospective, Randomized Brazilian GBTLI ALL-93 Protocol

in Pediatric Hematology and Hematological Malignancies

Silvia R. Brandalise
Marcos B. Viana
Vitória R. P. Pinheiro
Núbia Mendonça
Luiz F. Lopes
Waldir V. Pereira
Maria L. M. Lee
Elitânia M. Pontes
Gláucia P. Zouain-Figueiredo
Alita C. A. C. Azevedo

Frontiers in Pediatrics

doi 10.3389/fped.2016.00110

10,543 views
16 citations

Original Research

Published on 11 Sep 2025

Circulating tumor DNA to anticipate loco-regional recurrence in early-stage breast cancer: a proof-of-concept study

in Molecular and Cellular Oncology

Valentina Appierto
Elena Tamborini
Paola Tiberio
Adele Busico
Loris De Cecco
Marco Silvestri
Cinzia De Marco
Elena Cavadini
Maria Carmen De Santis
Secondo Folli

Frontiers in Oncology

doi 10.3389/fonc.2025.1621322

3,217 views

Original Research

Published on 19 Oct 2022

Survival for patients with metastatic colon cancer underwent cytoreductive colectomy in the era of rapid development of anticancer drugs: A real-world analysis based on updated population dataset of 2004–2018

in Pharmacology of Anti-Cancer Drugs

Guangran Meng
Shengtao Yang
Feixiang Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2022.983092

3,547 views
2 citations

Original Research

Published on 12 Apr 2021

Factors Modifying Outcome After MIBG Therapy in Children With Neuroblastoma—A National Retrospective Study

in Pediatric Oncology

Marek Ussowicz
Aleksandra Wieczorek
Agnieszka Dłużniewska
Anna Pieczonka
Robert Dębski
Katarzyna Drabko
Jolanta Goździk
Walentyna Balwierz
Daria Handkiewicz-Junak
Jacek Wachowiak

Frontiers in Oncology

doi 10.3389/fonc.2021.647361

7,247 views
11 citations

Mini Review

Published on 26 Nov 2015

Secondary Malignancy Risk Following Proton Radiation Therapy

in Radiation Oncology

Bree R. Eaton
Shannon M. MacDonald
Torunn I. Yock
Nancy J. Tarbell

Frontiers in Oncology

doi 10.3389/fonc.2015.00261

17,932 views
90 citations

Articles

Hypofractionated Whole-Breast Irradiation Focus on Coronary Arteries and Cardiac Toxicity—A Narrative Review

Constructing a cancer stem cell related prognostic model for predicting immune landscape and drug sensitivity in colorectal cancer

Shorter Maintenance Therapy in Childhood Acute Lymphoblastic Leukemia: The Experience of the Prospective, Randomized Brazilian GBTLI ALL-93 Protocol

Circulating tumor DNA to anticipate loco-regional recurrence in early-stage breast cancer: a proof-of-concept study

Survival for patients with metastatic colon cancer underwent cytoreductive colectomy in the era of rapid development of anticancer drugs: A real-world analysis based on updated population dataset of 2004–2018

Factors Modifying Outcome After MIBG Therapy in Children With Neuroblastoma—A National Retrospective Study

Secondary Malignancy Risk Following Proton Radiation Therapy